This in vivo study shows histologic evidence of laser-induced damage of fat. With further development, this might become a useful treatment for disorders involving the fat and/or lower dermis.
Background and Objectives: Use of thermal heating in microscopic zones has been applied for a number of applications. The objective of this study was to evaluate the benefits of using a 1,440-nm Nd-YAG laser (Affirm(TM), Cynosure, Westford, MA) using a different approach for microscopic heating. This device utilizes a microarray of lenses delivering a 10-mm beam as hundreds of regions of treatment distributed into high and low energy exposure. Study Design/Materials and Methods: Thirty-nine subjects (N ¼ 39) with superficial rhytides or scars received three to six treatments at 4-week intervals using the lens array. Total fluence ranged from 6.0 to 7.5 J/cm 2 . Zimmer air cooling was used for all treatments. No topical anesthetic was required. Results: Post-auricular histology showed areas of thermal injury up to approximately 250 m deep and 150 m wide. Of 80% patients who completed at least five treatments, 81% showed clinical improvement of 26-50% (on a quartile scale). The remainder showed less than 25% reduction in scars or rhytides. For the three treatment group, improvement in rhytides was 20%. Side effects were minimal and included mild post-treatment erythema and edema resolving within 24 hours. Pain during treatment was minimal.Conclusions: A 1,440-nm microlens array is a promising new approach to induce non-ablative neocollagenesis in the remodeling of scars and rhytids. Histologic evidence confirms the micro-columnar nature of collagen heating using this novel microlens array.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.